

| Organism | Homo sapiens, human | 
|---|---|
| Tissue | pancreas | 
| Product Format | frozen | 
| Morphology | epithelial | 
| Culture Properties | adherent | 
| Biosafety Level | 
				1
				 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.  | 
		
| Disease | adenocarcinoma | 
| Age | 64 years | 
| Gender | female | 
| Ethnicity | Caucasian | 
| Storage Conditions | liquid nitrogen vapor phase | 
| Karyotype | modal number = 61 | 
|---|---|
| Derivation | 
				 
					HPAC is a pancreatic adenocarcinoma epithelial cell line derived in 1985 from a nude mouse xenograft of a primary tumor removed from the head of the pancreas of a woman with moderate to well differentiated pancreatic adenocarcinoma of ductal origin.
				 
			 | 
		
| Clinical Data | 
				 
					64 years
				 
				
					female
				 
				
					Caucasian
				 
			 | 
		
| Receptor Expression | 
				 
					epidermal growth factor (EGF), expressed
				 
				
					glucocorticoid, expressed
				 
				
					epidermal growth factor (EGF); glucocorticoid
				 
			 | 
		
| Genes Expressed | 
				 
					HPAC cells are positive for keratin and negative for vimentin and chromogranin A.
				 
			 | 
		
| Tumorigenic | Yes | 
| Effects | 
				 
					Yes, the cells form tumors in athymic nude mice at the site of inoculation which are histologically similar to the tumor of origin
				 
				
					Yes, the cells have a colony forming efficiency of 64% on plastic and 3.2% in agarose.
				 
			 | 
		
| Comments | 
				 HPAC proliferation is stimulated by insulin, insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor alpha (TGF alpha). Cell growth is suppressed by dexamethasone and other glucocorticoids. 
					Crude HPAC cell exacts contained significant concentrations of tumor-associated antigens CEA, CA 125, and CA 19-9.
				 
				In culture, HPAC cells form monolayers of morphologically heterogenous polar epithelial cells. HPAC is the first reported human pancreatic adenocarcinoma cell line to express a functional glucocorticoid receptor. Immunohistochemical staining revealed that HPAC cells express the pancreatic ductal epithelium marker DU-PAN-2 as well as antigens recognized by the monoclonal antibodies HMFG1 and AUA1.  | 
		
| Complete Growth Medium | 
				A 1:1 mixture of Dulbecco''s modified Eagle''s medium and Ham''s F12 medium containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES and 0.5 mM sodium pyruvate supplemented with 0.002 mg/ml insulin, 0.005 mg/ml transferrin, 40 ng/ml hydrocortisone, 10 ng/ml epidermal growth factor and 5% fetal bovine serum  | 
		
|---|---|
| Subculturing | 
				Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. 
 Subculture Ratio: 1:3 to 1:6, every 6 to 8 days. 
					Medium Renewal: 2 to 3 times a week.
				 
				
					Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.
				 
			 | 
		
| Cryopreservation | 
				 
					Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
				 
				
					Storage temperature: liquid nitrogen vapor phase
				 
			 | 
		
| Culture Conditions | 
				Temperature: 37¡ãC Atmosphere: Air, 95%; carbon dioxide (CO2), 5%  | 
		


